辛巴退网留谜局：妻子掌权无股份，爱徒蛋蛋疑遭直播间“屏蔽”

Group 1 - The core point of the article is that prominent live-streaming host Xin Youzhi (Xin Ba) has announced his permanent retirement from online activities due to health issues, transferring company control to his wife, Chu Ruixue, although she does not hold significant shares in the company [2][4][5] - Xin Youzhi has previously announced his retirement multiple times, with the latest being on August 18, 2023, citing health concerns, including significant hair loss and lung issues [4][5] - Despite the transfer of control to his wife, Xin Youzhi remains the legal representative of Guangzhou Xin Xuan Investment Co., Ltd., holding 95% of the shares, indicating he still has substantial influence over the company [4][5] Group 2 - There are concerns regarding the relationship between Xin Youzhi's disciple, Dan Dan, and the company, as she has claimed that 99% of the account will belong to her in the future, but her name was recently blocked in Xin Youzhi's live stream, suggesting potential conflicts [7][9] - Dan Dan has gained significant popularity, surpassing Xin Youzhi in sales rankings, and has over 110 million followers on the Kuaishou platform [7][9] - There have been previous tensions between Dan Dan and Chu Ruixue, leading to public disputes and a need for Xin Youzhi to mediate, raising questions about the stability of the leadership transition [9][10] Group 3 - The "Mian Mima" sanitary napkin controversy continues to affect the company, as it has been accused of containing carcinogenic substances, with products still available for sale despite ongoing consumer concerns [10][12][13] - Xin Youzhi has stated his intention to address these issues after his retirement, but the company still has products from the "Mian Mima" brand listed for sale, indicating a potential conflict between addressing health concerns and maintaining sales [12][13] - The sanitary napkin brand, launched by Xin Youzhi in 2017, has faced scrutiny after reports of harmful chemical content, leading to consumer backlash and calls for accountability [12][13]